The report on the Global Recombinant Expression Systems Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
An expression system is a system specifically designed for the production of a gene product of choice. This is normally a protein although may also be RNA, such as tRNA or a ribozyme. An expression system consists of a gene, normally encoded by DNA, and the molecular machinery required to transcribe the DNA into mRNA and translate the mRNA into protein using the reagents provided. Expression systems are classified on the basis of functionality, solubility, yield, level of target gene expression, and post translational processing.
The recombinant expression systems market is expected to grow owing to increased research in pharmaceutical sector and growth in biologics market. The overall growth in proteomics market is also a major factor driving this market. Decreased R&D expenditure and high market consolidation will hamper the growth of this market. Developing countries are expected to be high opportunity regions for global recombinant expression systems market.
This report segments the global recombinant expression market based on expression systems, products, and end users. This market is segmented on the basis of expression systems into insect cell expression systems, mammalian cell expression systems, prokaryotic expression systems, yeast expression systems, and other expression systems. On the basis of products, global recombinant expression systems market is segments include competent cells, expression vectors, instruments, reagents, expression vectors, instruments, reagents, and services. Academic research institutes, contract research organizations (CRO), pharmaceutical and biotechnology companies, and other end users Hospitals, diagnostic laboratories, research institutes, and others are the end-user segmentation of the recombinant expression systems market. The geographic segments included in this report are North America, Europe, Asia and Rest of the World.
Some of the major players of recombinant expression systems market include:
TABLE OF CONTENTS
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Recombinant Expression Systems Market
2.2. Global Recombinant Expression Systems Market Snapshot
3 . RECOMBINANT EXPRESSION SYSTEMS – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Recombinant Expression Systems Market
3.3. Market Restraints of Recombinant Expression Systems Market
3.4. Opportunities of Recombinant Expression Systems Market
3.5. Trends of Recombinant Expression Systems Market
3.6. Porter’s Five Force Analysis of Recombinant Expression Systems Market
3.7. Recombinant Expression Systems Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Expression Systems
3.7.2 Market Attractive Analysis by Products
3.7.3 Market Attractive Analysis by End User
3.7.4 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Recombinant Expression Systems Value Chain Analysis
4.2. Recombinant Expression Systems Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Recombinant Expression Systems Raw Material Manufactures List
4.2.3. Price Trend of Recombinant Expression Systems Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL RECOMBINANT EXPRESSION SYSTEMS MARKET ANALYSIS BY EXPRESSION SYSTEMS
5.1 Overview by Expression Systems
5.2 Global Recombinant Expression Systems Market Analysis by Expression Systems
5.3 Market Analysis of Insect Cell Expression Systems by Regions
5.4 Market Analysis of Mammalian Cell Expression Systems by Regions
5.5 Market Analysis of Prokaryotic Expression Systems by Regions
5.6 Market Analysis of Yeast Expression Systems by Regions
5.7 Market Analysis of Other Expression Systems by Regions
6 . GLOBAL RECOMBINANT EXPRESSION SYSTEMS MARKET ANALYSIS BY PRODUCTS
6.1 Overview by Products
6.2 Global Recombinant Expression Systems Market Analysis by Products
6.3 Market Analysis of Competent Cells by Regions
6.4 Market Analysis of Expression Vectors by Regions
6.5 Market Analysis of Instruments by Regions
6.6 Market Analysis of Reagents by Regions
6.7 Market Analysis of Expression Vectors by Regions
6.8 Market Analysis of Instruments by Regions
6.9 Market Analysis of Reagents by Regions
6.10. Market Analysis of Services by Regions
7 . GLOBAL RECOMBINANT EXPRESSION SYSTEMS MARKET ANALYSIS BY END USER
7.1 Overview by End User
7.2 Global Recombinant Expression Systems Market Analysis by End User
7.3 Market Analysis of Academic Research Institutes by Regions
7.4 Market Analysis of Contract Research Organizations (CRO) by Regions
7.5 Market Analysis of Pharmaceutical and biotechnology companies by Regions
7.6 Market Analysis of Other end users by Regions
8 . GLOBAL RECOMBINANT EXPRESSION SYSTEMS MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America
8.3.1. Overview
8.3.2. North America Recombinant Expression Systems Market Estimate by Country
8.3.3. United State
8.3.4. Rest of North America
8.4. Europe
8.4.1. Overview
8.4.2. Europe Recombinant Expression Systems Market Estimate by Market Segment
8.4.3. Europe Recombinant Expression Systems Market Estimate by Country
8.4.4. United Kingdom
8.4.5. France
8.4.6. Germany
8.4.7 Rest of Europe
8.5. Asia Pacific
8.5.1. Overview
8.5.2. Asia Pacific Recombinant Expression Systems Market Estimate by Market Segment
8.5.3. Asia Pacific Recombinant Expression Systems Market Estimate by Country
8.5.4. China
8.5.5. Japan
8.5.6. India
8.5.7. Rest of Asia Pacific
8.6. Latin America
8.6.1. Overview
8.6.2. Latin America Recombinant Expression Systems Market Estimate by Market Segment
8.6.3. Latin America Recombinant Expression Systems Market Estimate by Country
8.6.4. Brazil
8.6.5. Rest of Latin America
8.7. Middle East & Africa
8.7.1. Overview
8.7.2. Middle East & Africa Recombinant Expression Systems Market Estimate by Market Segment
8.7.3. Middle East & Africa Recombinant Expression Systems Market Estimate by Country
8.7.4. Middle East
8.7.5. Africa
9 . COMPETITIVE LANDSCAPE OF THE RECOMBINANT EXPRESSION SYSTEMS COMPANIES
9.1. Recombinant Expression Systems Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF RECOMBINANT EXPRESSION SYSTEMS INDUSTRY
10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Agilent Technologies, Inc
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products
10.3.4. Recent Developments
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products
10.4.4. Recent Developments
10.5. Life Technologies Corporation
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products
10.5.4. Recent Developments
10.6. Merck Millipore
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products
10.6.4. Recent Developments
10.7. New England Biolabs, Inc.
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products
10.7.4. Recent Developments
10.8. Promega Corporation
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products
10.8.4. Recent Developments
10.9. Qiagen
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products
10.9.4. Recent Developments
10.10. Sigma-Aldrich Corporation
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products
10.10.4. Recent Developments
10.11. Takara Bio, Inc.
10.11.1. Company Overview
10.11.2. Financials
10.11.3. Products
10.11.4. Recent Developments
10.12. Thermo Fischer Scientific Inc.
10.12.1. Company Overview
10.12.2. Financials
10.12.3. Products
10.12.4. Recent Developments
*Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
Opioids Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast read more..
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..